Vaccine | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News The Market Buzz

Johnson & Johnson Pauses Coronavirus Vaccine Trial

Rebecca Urena10/13/2020

1756

Johnson & Johnson (NYSE: JNJ), one of the pharmaceutical company’s striving to develop a COVID-19 vaccine, has paused it’s late-stage trial following an “adverse event” in one of its...

Healthcare Investing News Market News Technology The Market Buzz

Facebook to Support Public Health Experts in Vaccine efforts

Bryan Shin10/13/2020

1749

Facebook, Inc. (NASDAQ: FB) has announced new steps to help support vaccine efforts. These steps include, launching a campaign of information on new flu vaccine details such as product...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Moderna (NASDAQ: MRNA) Slows Trial after Failing to Include Enough Minority Participants

financial buzz10/06/202010/06/2020

929

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Moderna Slows Trail After Failing to Include Enough Minority Participants” Moderna, Inc. (NASDAQ: MRNA) slowed enrollment of its...

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Moderna Anticipates to Have Coronavirus Vaccine Answers by November

Rebecca Urena09/17/202009/17/2020

3442

Moderna’s (NASDAQ: MRNA) CEO, Stephane Bancel, announced Thursday that the company should have an answer as to whether its coronavirus vaccine is successful or not by November. “If the...

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Novavax Shares Surge Amid U.K Agreement to Deliver Coronavirus Vaccine

Rebecca Urena08/14/2020

6190

Novavax (NASDAQ: NVAX) shares surged Friday amid the news that the company had come to an agreement with the U.K. to deliver 60 million doses of its promising coronavirus...

Biotechnology Healthcare Investing News Life Style Market News Pharmaceutical The Market Buzz Your Environment

Johnson & Johnson to Deliver U.S 100 Million Doses of Coronavirus Vaccine

Rebecca Urena08/05/2020

5430

Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it has reached an agreement with the U.S. to provide 100 million doses of it COVID-19 vaccine for a sum of...

Investing News Market News Technology

BioNTech SE and Pfizer Inc. announced initial data from their ongoing German Phase ½ COVID-19 Vaccine Study

Danny Abramov07/20/2020

4295

BioNTech SE (NASDAQ: BNTX) and Pfizer Inc. (NYSE: PFE) announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global...

Healthcare Investing News Market News Technology The Market Buzz

J&J Profit Plummets 35%

Rebecca Urena07/16/202007/16/2020

4863

Johnson & Johnson (NYSE: JNJ) second quarter profit plummets 35% amid the coronavirus pandemic. The lack of demand for beauty products and medical equipment has taken a toll on...

Biotechnology Healthcare Investing News Market News

Biotech Sector Pursues a Vaccine as COVID-19 Cases Continue to Rise

Danny Abramov06/26/2020

11369

The number of new COVID-19 cases per day in the United States continues to rise. While significantly expanded testing probably accounts for the increase in numbers, some experts claim...

Investing News Market News

Catalent and Moderna Report Collaboration to Manufacture Moderna’s Coronavirus Vaccine Candidate

Bryan Shin06/25/2020

5271

Moderna, Inc. (NASDAQ: MRNA) and Catalent, Inc. (NYSE: CTLT) have announced a collaboration to large scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics...

Tag: Vaccine